Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines

Keyphrases

• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 100%
• Overexpression 100%
• Topoisomerase Inhibitors 100%
• Glioblastoma Cell Lines 100%
• Overexpressing 26%
• Glioblastoma 26%
• No Significant Difference 13%
• U87MG 13%
• TOP1 Inhibitor 13%
• Poor Prognosis 6%
• Bevacizumab 6%
• Irinotecan 6%
• Cancer Types 6%
• Second-line Treatment 6%
• Epirubicin 6%
• Response to Chemotherapy 6%
• Predictive Potential 6%
• Multifunctional Protein 6%
• Cellular Level 6%
• Subclone 6%
• SN-38 6%
• Reduced Growth 6%
• Top2 6%
• Glioblastoma Cells 6%
• Vascular Endothelial Growth Factor Antibody 6%
• Irinotecan Resistance 6%
• Spheroid Formation 6%
• U87 Cells 6%
• A172 Cells 6%
• Organotypic Brain Slice Culture 6%
• A172 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Tissue Inhibitor of Metalloproteinase 1 100%
• Glioblastoma 100%
• DNA Topoisomerase Inhibitor 100%
• Irinotecan 13%
• Malignant Neoplasm 6%
• Chemotherapy 6%
• Bevacizumab 6%
• Epirubicin 6%
• Vasculotropin Antibody 6%

Neuroscience

• Cell Line 100%
• Metalloprotease Inhibitor 100%
• Topoisomerase Inhibitor 100%
• Irinotecan 13%
• Bevacizumab 6%
• Brain Slice 6%
• SN-38 6%
• Vasculotropin Antibody 6%
• Epirubicin 6%